Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Genetic Neurodegenerative Diseases, and Neuroinflammation and Neurodegeneration Mechanisms.
Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle <scp>2A</scp> in Early <scp>Drug‐Naive</scp> Parkinson's Disease
Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum
Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications
Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
Cortical thinning across Parkinson's disease stages and clinical correlates
Speech difficulties in early de novo patients with Parkinson's disease
[18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment
Diabetes mellitus and Parkinson disease
Advances in MRI Methodology
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease
Serotonergic dysregulation is linked to sleep problems in Parkinson's disease
Neuroimaging in Lewy body dementia
Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease
PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology
Cerebral serotonin transporter measurements with [ <sup>11</sup> C]DASB: A review on acquisition and preprocessing across 21 PET centres
Disease-related patterns of in vivo pathology in Corticobasal syndrome
Molecular Imaging of the Serotonergic System in Parkinson's Disease
Cognitive decline in Parkinson disease
The psychosis spectrum in Parkinson disease
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers
PET image reconstruction using multi-parametric anato-functional priors
<sup>11</sup>C‐PE2I and <sup>18</sup>F‐Dopa PET for assessing progression rate in Parkinson's: A longitudinal study